Vanguard Asset Management
ABBV icon

Vanguard Asset Management’s AbbVie ABBV Stock Holding History

Vanguard Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.12B Buy
4,298,191
+302,749
+8% +$77.6M 0.7% 20
2026
Q2 		$1.01B Buy
3,995,442
+435,623
+12% +$93.7M 0.68% 23
2026
Q1 		$774M Buy
+3,559,819
New +$790M 0.66% 19

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Vanguard Asset Management's ABBV Position: Q3 2026 in Review

Vanguard Asset Management increased its AbbVie (ABBV) stake by 7.6% in Q3 2026, buying an estimated $77.6M and bringing the position to 4,298,191 shares worth $1.12B. The position accounts for 0.7% of the portfolio, ranked #20.

Vanguard Asset Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Vanguard Asset Management held 4,298,191 shares of AbbVie worth $1.12B as of Q3 2026.
  • Vanguard Asset Management bought 302,749 AbbVie shares in Q3 2026, an estimated $77.6M.
  • AbbVie made up 0.7% of Vanguard Asset Management's portfolio in Q3 2026, its #20 holding.
  • Vanguard Asset Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.